Hadas Nicole R.
Insider CIK 1602396 · AKBA VP General Counsel & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-05-13 | 2024-05-14 | 12,016 | $1.26 | $15.1K | 651,243 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 5,974 | $1.58 | $9.4K | 663,259 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-29 | 7,411 | $1.52 | $11.3K | 669,233 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 224,000 | — | $0 | 224,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 149,300 | — | $0 | 676,644 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-05-25 | 2023-05-25 | 63,186 | $1.22 | $77.1K | 524,344 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-05-24 | 2023-05-25 | 200,000 | — | $0 | 587,530 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-05-12 | 2023-05-16 | 100,000 | — | $0 | 387,530 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 5,333 | $0.88 | $4.7K | 295,231 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 6,613 | $0.88 | $5.8K | 288,618 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 1,088 | $0.88 | $957 | 287,530 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-02-27 | 2023-03-01 | 6,677 | $0.81 | $5.4K | 300,564 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 6,873 | $2.17 | $14.9K | 308,875 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 6,556 | $2.17 | $14.2K | 302,319 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 1,078 | $2.17 | $2.3K | 304,241 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-02-28 | 2022-03-02 | 50,000 | — | $0 | 315,748 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 6,555 | $2.15 | $14.1K | 265,748 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-01 | 1,060 | $3.40 | $3.6K | 272,303 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-03-16 | 2021-03-18 | 10,192 | — | $0 | 273,363 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 7,976 | $3.40 | $27.1K | 263,171 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 6,309 | $3.40 | $21.5K | 271,147 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-02-26 | 2021-03-02 | 62,000 | — | $0 | 277,456 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-02 | 105,000 | — | $0 | 105,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-02-28 | 2020-03-02 | 7,050 | $8.70 | $61.3K | 212,756 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-02 | 62,000 | — | $0 | 219,806 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | D To issuer | 2019-04-11 | 2019-04-12 | 11,929 | $7.70 | $91.9K | 154,806 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-02-28 | 2019-03-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-02-28 | 2019-03-05 | 65,000 | — | $0 | 166,735 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | F Tax w/h | 2018-12-12 | 2018-12-13 | 20,175 | $8.94 | $180.4K | 101,284 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-02-28 | 2018-03-02 | 17,500 | — | $0 | 120,078 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 1,553 | $19.64 | $30.5K | 108,054 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 6,250 | $19.95 | $124.7K | 101,804 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-07-03 | 2017-07-06 | 1,554 | $14.26 | $22.2K | 109,607 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 1,556 | $9.18 | $14.3K | 109,856 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 45,000 | $10.14 | $456.3K | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2017-02-21 | 2017-02-23 | 28,500 | — | $0 | 111,412 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-01-01 | 2017-01-03 | 1,810 | $10.49 | $19.0K | 82,912 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-10-01 | 2016-10-04 | 1,556 | $8.95 | $13.9K | 83,915 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-07-05 | 2016-07-06 | 1,557 | $7.47 | $11.6K | 85,471 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-04-04 | 2016-04-05 | 1,556 | $9.41 | $14.6K | 85,528 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-02-22 | 2016-02-24 | 34,300 | — | $0 | 34,300 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2016-02-22 | 2016-02-24 | 22,500 | — | $0 | 87,084 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-01-04 | 2016-01-06 | 1,811 | $12.28 | $22.2K | 64,584 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-10-02 | 2015-10-05 | 1,484 | $8.67 | $12.9K | 65,260 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-07-02 | 2015-07-06 | 1,484 | $9.54 | $14.2K | 66,744 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-04-02 | 2015-07-02 | 1,483 | $9.09 | $13.5K | 67,015 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-04-02 | 2015-04-06 | 1,483 | $9.09 | $13.5K | 76,093 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-04-01 | 2015-04-06 | 4,539 | $9.51 | $43.2K | 77,576 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-03-06 | 2015-03-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-01-02 | 2015-07-02 | 1,715 | $11.46 | $19.7K | 68,498 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-01-02 | 2015-01-05 | 1,715 | $11.46 | $19.7K | 73,037 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-01-01 | 2015-01-05 | 4,539 | $11.64 | $52.8K | 74,752 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | F Tax w/h | 2014-12-02 | 2014-12-03 | 5,910 | $11.43 | $67.6K | 70,213 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2014-05-14 | 2014-08-05 | 16,667 | — | $0 | 16,667 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-03-25 | 2014-03-27 | 3,500 | $17.00 | $59.5K | 76,123 | SEC↗ |